COPD
Conditions
Interventions
None listed
Sponsors
AstraZeneca.KK.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Patients from whom written consent to participate in this study has been obtained. -Females and males aged 40 years or older at the time of registration, who were diagnosed with COPD by physicians (patients with forced expiratory volume in one second/ forced vital capacity [FEV1/FVC] ratio <70% post-bronchodilator inhalation within the past year or on registration). -Patients who have lung function tests performed within the past three months as well as within the past two years on the registration. -Patients who have chest CT performed within the past year or on registration. -Outpatients deemed capable of answering the questionnaires within 8 weeks following registration and measuring their daily step counts using pedometers for 14 consecutive days.
Exclusion criteria
Exclusion criteria: -Patients who participated in other interventional studies including clinical trials within the last 3 months. -Patients who are suspected to have a poor capability to follow study instructions (e.g. due to a history of alcoholism or drug abuse, planned to admission during the study, or dementia) or patients judged by physicians as whom would have obviously biased outcomes due to their other diseases (e.g. Osteoarthritis, mental illness, dementias, tumors, etc...). -Patients with exacerbations within the last 8 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Daily step of patients with COPD 2)Average time of each activity level 3)Correlation between physical activity level and other factor | — |
Countries
Japan
Contacts
Public ContactTatsunori Jinnai
AstraZeneca.KK. Medical
Outcome results
None listed